Exam Cram

• ALL: acute lymphoblastic leukaemia

• Presentation: childhood cancer

• Prognosis: good

Outline

Background

Peak incidence: 1-4yrs, rare in adulthood. 

Investigations

• Leukocytosis

Management

Chemotherapy: good response

Immunotherapy: tyrosine kinase inhibitors

Reference

1. Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020 Apr 4;395(10230):1146-1162. doi: 10.1016/S0140-6736(19)33018-1. PMID: 32247396. 

Cite this page:

Munro (2024) Munro Medics - Acute Lymphoblastic Leukaemia, Munromedics.com. Available at: https://www.munromedics.com/pathology/az-disease/a/aa-ac/acute-lymphoblastic-leukaemia (Accessed: 26 December 2024).